首页 > 最新文献

Medico e Bambino最新文献

英文 中文
Il nirsevimab nella prevenzione della bronchiolite da virus respiratorio sinciziale 尼舍单抗在预防呼吸道合胞病毒支气管炎中的应用
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43239
Alessandra Consolati, Maria Paola Farinelli, Paolo Serravalle, Christine Rollandin, L. Apprato, Salvatore Bongiorno
Background RSV is the leading cause of hospitalization for respiratory infections in infants, such as bronchiolitis. In the epidemic season 2023-2024, in Valle D’Aosta Region of Italy (VdA) a universal prevention program against RSV was implemented to protect all infants aged less than 6 months with Nirsevimab. Here we present preliminary data as of 15Feb/2023 regarding coverage rate and effectiveness of nirsevimab. Methods Written consent to the administration of Nirsevimab and the processing of health data was obtained from parents. Nirsevimab administration data were extrapolated from electronic health records managed by Health Authority of VdA, while hospitalizations data for RSV bronchiolitis were extrapolated from hospital discharge records of the same VdA. Results Nirsevimab was available for all infants from 20/Dec/2023. Coverage rates were 65% (292/448) for infants born from 1/May/2023 to 18/Dec/2023, and 86% (77/89) for infants born from 20/Dec/2023 to 15/Feb/2024. There have been 29 hospitalizations for RSV bronchiolitis, 18 in infants born after 1/May/2023. In the past epidemic season 2022/2023, on the same date, the number of hospitalizations was 61, of which 47 in children born after 1/May/2022. The prevalence of RSV bronchiolitis hospitalization in infants who did not receive Nirsevimab was 8.3% (14/168), while there were no hospitalizations due to RSV bronchiolitis in infants who received Nirsevimab (0/369), p<0.001 (Fisher’s exact test). Conclusions The high coverage rate and the solid effectiveness results of Nirsevimab in VdA, as already demonstrated in other countries such as US, Spain, France, Luxemburg, may support Italian policy makers in the implementation of RSV prevention program among the entire country in the next year. Further data on safety and effectiveness on full epidemic season will better explain the potential of this prevention programme.
背景 RSV 是导致婴儿呼吸道感染(如支气管炎)住院的主要原因。在 2023-2024 年流行季节,意大利瓦莱达奥斯塔大区(VdA)实施了一项针对 RSV 的全民预防计划,用尼舍维单抗保护所有 6 个月以下的婴儿。我们在此提供截至 2023 年 2 月 15 日有关尼舍单抗覆盖率和有效性的初步数据。方法 征得家长对使用尼舍单抗和处理健康数据的书面同意。尼尔舍维单抗的用药数据来自弗吉尼亚州卫生局管理的电子健康记录,RSV 支气管炎的住院数据则来自同一弗吉尼亚州卫生局的出院记录。结果 自 2023 年 12 月 20 日起,所有婴儿均可使用 Nirsevimab。2023 年 5 月 1 日至 2023 年 12 月 18 日出生的婴儿的覆盖率为 65%(292/448),2023 年 12 月 20 日至 2024 年 2 月 15 日出生的婴儿的覆盖率为 86%(77/89)。有 29 例 RSV 支气管炎住院病例,其中 18 例发生在 2023 年 5 月 1 日之后出生的婴儿身上。在过去的流行季节 2022/2023 年的同一天,住院人数为 61 人,其中 47 人是在 2022 年 5 月 1 日之后出生的婴儿。未接受尼尔赛维单抗治疗的婴儿中,RSV 支气管炎住院率为 8.3%(14/168),而接受尼尔赛维单抗治疗的婴儿中,没有因 RSV 支气管炎住院的(0/369),P<0.001(费雪精确检验)。结论 Nirsevimab 在 VdA 的高覆盖率和可靠的有效性结果,已经在美国、西班牙、法国、卢森堡等其他国家得到证实,这可能有助于意大利决策者明年在全国范围内实施 RSV 预防计划。有关整个流行季节的安全性和有效性的进一步数据将更好地解释该预防计划的潜力。
{"title":"Il nirsevimab nella prevenzione della bronchiolite da virus respiratorio sinciziale","authors":"Alessandra Consolati, Maria Paola Farinelli, Paolo Serravalle, Christine Rollandin, L. Apprato, Salvatore Bongiorno","doi":"10.53126/meb43239","DOIUrl":"https://doi.org/10.53126/meb43239","url":null,"abstract":"Background RSV is the leading cause of hospitalization for respiratory infections in infants, such as bronchiolitis. In the epidemic season 2023-2024, in Valle D’Aosta Region of Italy (VdA) a universal prevention program against RSV was implemented to protect all infants aged less than 6 months with Nirsevimab. Here we present preliminary data as of 15Feb/2023 regarding coverage rate and effectiveness of nirsevimab. Methods Written consent to the administration of Nirsevimab and the processing of health data was obtained from parents. Nirsevimab administration data were extrapolated from electronic health records managed by Health Authority of VdA, while hospitalizations data for RSV bronchiolitis were extrapolated from hospital discharge records of the same VdA. Results Nirsevimab was available for all infants from 20/Dec/2023. Coverage rates were 65% (292/448) for infants born from 1/May/2023 to 18/Dec/2023, and 86% (77/89) for infants born from 20/Dec/2023 to 15/Feb/2024. There have been 29 hospitalizations for RSV bronchiolitis, 18 in infants born after 1/May/2023. In the past epidemic season 2022/2023, on the same date, the number of hospitalizations was 61, of which 47 in children born after 1/May/2022. The prevalence of RSV bronchiolitis hospitalization in infants who did not receive Nirsevimab was 8.3% (14/168), while there were no hospitalizations due to RSV bronchiolitis in infants who received Nirsevimab (0/369), p<0.001 (Fisher’s exact test). Conclusions The high coverage rate and the solid effectiveness results of Nirsevimab in VdA, as already demonstrated in other countries such as US, Spain, France, Luxemburg, may support Italian policy makers in the implementation of RSV prevention program among the entire country in the next year. Further data on safety and effectiveness on full epidemic season will better explain the potential of this prevention programme.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"92 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140659471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening e comunicazione 筛查和交流
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43249
D. Baronciani
Confrontarsi con l’incertezza a partire dagli originali criteri per adottare uno screening che sono quelli del 1968 di Wilson e Jungner.
从最初的筛选标准,即 1968 年威尔逊和荣格纳提出的标准出发,面对不确定性。
{"title":"Screening e comunicazione","authors":"D. Baronciani","doi":"10.53126/meb43249","DOIUrl":"https://doi.org/10.53126/meb43249","url":null,"abstract":"Confrontarsi con l’incertezza a partire dagli originali criteri per adottare uno screening che sono quelli del 1968 di Wilson e Jungner.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140660425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening per diabete mellito tipo 1 e celiachia: intenzioni, pregi e difetti 1 型糖尿病和乳糜泻筛查:意图、优点和缺点
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43243
G. Tornese, L. Greco
Italy is the first country in the world to have introduced screening on the entire pediatric population for type 1 diabetes mellitus and celiac disease which will be preceded by a preparatory pilot study in 4 regions and on approximately 5000 children aged 2, 6 and 10 years of age. In this article we will give some practical information on screening and we will try to give the reasons for screening and any doubts, keeping in mind the Wilson and Jungner screening criteria.
意大利是世界上第一个对所有儿童进行 1 型糖尿病和乳糜泻筛查的国家,在此之前将在 4 个地区对大约 5000 名 2 岁、6 岁和 10 岁的儿童进行预备性试点研究。在这篇文章中,我们将提供一些有关筛查的实用信息,并将根据威尔逊和荣格纳的筛查标准,尝试说明进行筛查的原因和存在的疑问。
{"title":"Screening per diabete mellito tipo 1 e celiachia: intenzioni, pregi e difetti","authors":"G. Tornese, L. Greco","doi":"10.53126/meb43243","DOIUrl":"https://doi.org/10.53126/meb43243","url":null,"abstract":"Italy is the first country in the world to have introduced screening on the entire pediatric population for type 1 diabetes mellitus and celiac disease which will be preceded by a preparatory pilot study in 4 regions and on approximately 5000 children aged 2, 6 and 10 years of age. In this article we will give some practical information on screening and we will try to give the reasons for screening and any doubts, keeping in mind the Wilson and Jungner screening criteria.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"61 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140664181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infezione da West Nile Virus 西尼罗河病毒感染
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43233
F. Orsi, Giulia Bini, G. Baroncelli, A. Bonuccelli, D. Peroni
West Nile Virus infection in children may usually occur as a self-limiting febrile illness or rarely as a neuroinvasive disease with possible late neurological sequelae. Therefore, the paediatrician should take into consideration this condition in febrile children who also showed neurological signs or symptoms. Early recognition of the disease and appropriate management may result in a favorable prognosis.
儿童感染西尼罗河病毒通常可能是一种自限性发热性疾病,也可能是一种罕见的神经侵袭性疾病,并可能伴有晚期神经系统后遗症。因此,如果发热儿童同时出现神经系统体征或症状,儿科医生应考虑到这种情况。及早发现这种疾病并采取适当的治疗措施可获得良好的预后。
{"title":"Infezione da West Nile Virus","authors":"F. Orsi, Giulia Bini, G. Baroncelli, A. Bonuccelli, D. Peroni","doi":"10.53126/meb43233","DOIUrl":"https://doi.org/10.53126/meb43233","url":null,"abstract":"West Nile Virus infection in children may usually occur as a self-limiting febrile illness or rarely as a neuroinvasive disease with possible late neurological sequelae. Therefore, the paediatrician should take into consideration this condition in febrile children who also showed neurological signs or symptoms. Early recognition of the disease and appropriate management may result in a favorable prognosis.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"62 29","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140664120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La sindrome di Stickler Stickler 综合征
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43251
L. Cazzaniga, Michele Abramo, A. Selicorni
“Occhio” alle sequenze di Pierre-Robin, soprattutto se “dure d’orecchio”
注意 "皮埃尔-罗宾序列,尤其是 "听力不好的人
{"title":"La sindrome di Stickler","authors":"L. Cazzaniga, Michele Abramo, A. Selicorni","doi":"10.53126/meb43251","DOIUrl":"https://doi.org/10.53126/meb43251","url":null,"abstract":"“Occhio” alle sequenze di Pierre-Robin, soprattutto se “dure d’orecchio”","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"58 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140665972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La profilassi dell'infezione da virus respiratorio sinciziale: dal dire al fare? 预防呼吸道合胞病毒感染:从说到做?
Q4 Medicine Pub Date : 2024-04-24 DOI: 10.53126/meb43211
Federico Marchetti
Alcuni stati europei hanno introdotto la prevenzione universale con il nirsevimab con risultati favorevoli, così come dimostrerebbe l’esperienza pilota della Valle d’Aosta (pag. 239). Si tratta di definire in modo molto pratico cosa fare nel panorama “nazionale” per la prossima stagione.
正如瓦莱达奥斯塔(Valle d'Aosta)的试点经验(第 239 页)所表明的那样,一些欧洲国家已开始使用 nirsevimab 进行普遍预防,并取得了良好的效果。这就需要以非常务实的方式确定下一季度在 "国家 "范围内应采取的行动。
{"title":"La profilassi dell'infezione da virus respiratorio sinciziale: dal dire al fare?","authors":"Federico Marchetti","doi":"10.53126/meb43211","DOIUrl":"https://doi.org/10.53126/meb43211","url":null,"abstract":"Alcuni stati europei hanno introdotto la prevenzione universale con il nirsevimab con risultati favorevoli, così come dimostrerebbe l’esperienza pilota della Valle d’Aosta (pag. 239). Si tratta di definire in modo molto pratico cosa fare nel panorama “nazionale” per la prossima stagione.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":"42 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140665871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le colelitiasi a origine ematologica 血源性胆石症
Q4 Medicine Pub Date : 2024-03-25 DOI: 10.53126/meb43187
Marialetizia Fantasia, Martha Caterina Faraguna, G. Ferrari, P. Corti
Circa il 20% delle colelitiasi presenta una origine ematologica, non sempre facile da diagnosticare. Una emolisi cronica deve essere sempre ricercata in presenza di calcoli della colecisti, soprattutto in età pediatrica e tra le possibili cause la sferocitosi (spesso misconosciuta) è quella tra le più frequenti.
大约 20% 的胆石症是由血液病引起的,但这并不容易诊断。在出现胆结石时,尤其是在儿童时期,必须始终注意慢性溶血,而在可能的病因中,球形红细胞增多症(经常被误解)是最常见的一种。
{"title":"Le colelitiasi a origine ematologica","authors":"Marialetizia Fantasia, Martha Caterina Faraguna, G. Ferrari, P. Corti","doi":"10.53126/meb43187","DOIUrl":"https://doi.org/10.53126/meb43187","url":null,"abstract":"Circa il 20% delle colelitiasi presenta una origine ematologica, non sempre facile da diagnosticare. Una emolisi cronica deve essere sempre ricercata in presenza di calcoli della colecisti, soprattutto in età pediatrica e tra le possibili cause la sferocitosi (spesso misconosciuta) è quella tra le più frequenti.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":" 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140210077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allergia agli antibiotici beta-lattamici: i miti da sfatare e le azioni pratiche da adottare β-内酰胺类抗生素过敏:消除误解,采取实际行动
Q4 Medicine Pub Date : 2024-03-25 DOI: 10.53126/meb43155
L. Badina, Federico Marchetti, Simone Fontijn, I. Berti
The penicillins (amoxicillin) are among the most effective and safe antibiotics for many common bacterial respiratory infections in paediatric age and should be avoided only when a true allergy is highly suspected. Severe true antibiotic allergies are rare and allergies are often overestimated. In high-income countries, 5-15% of patients report a penicillin allergy. However, in most cases (> 95%), these patients do not have a true immunologically mediated allergy and they may very likely tolerate the antibiotic upon a new exposure. All patients defined as allergic should be carefully evaluated and their levels of antibiotic allergy risk determined. In cases of suspected penicillin allergy (e.g. those with cutaneous manifestations), skin tests are not necessary before prescribing a beta-lactam antibiotic (amoxicillin) and direct oral administration can be performed in low-risk phenotypes carefully selected according to simple protocols that do not always require a specialist evaluation. The article, based on the recommendations of the WHO Aware Manual, provides current evidence and practical guidance, and fosters a correct interpretation and management of an overestimated problem that does not promote an optimal and judicious antibiotic use.
青霉素类(阿莫西林)是治疗儿科常见细菌性呼吸道感染最有效、最安全的抗生素之一,只有在高度怀疑真正过敏时才应避免使用。严重的真正抗生素过敏很少见,而且过敏往往被高估。在高收入国家,5%-15% 的患者报告对青霉素过敏。然而,在大多数情况下(> 95%),这些患者并没有真正的免疫介导过敏,他们很可能在重新接触抗生素后仍能耐受。所有被定义为过敏的患者都应接受仔细评估,并确定其抗生素过敏风险水平。对于疑似青霉素过敏的病例(如有皮肤表现的病例),在开具β-内酰胺类抗生素(阿莫西林)处方前无需进行皮试,可根据简单的方案对低风险表型进行仔细筛选后直接口服给药,并不一定需要专科医生进行评估。这篇文章以世界卫生组织《认识手册》的建议为基础,提供了最新的证据和实用指南,有助于正确解释和处理被高估的问题,因为高估的问题并不能促进最佳和明智地使用抗生素。
{"title":"Allergia agli antibiotici beta-lattamici: i miti da sfatare e le azioni pratiche da adottare","authors":"L. Badina, Federico Marchetti, Simone Fontijn, I. Berti","doi":"10.53126/meb43155","DOIUrl":"https://doi.org/10.53126/meb43155","url":null,"abstract":"The penicillins (amoxicillin) are among the most effective and safe antibiotics for many common bacterial respiratory infections in paediatric age and should be avoided only when a true allergy is highly suspected. Severe true antibiotic allergies are rare and allergies are often overestimated. In high-income countries, 5-15% of patients report a penicillin allergy. However, in most cases (> 95%), these patients do not have a true immunologically mediated allergy and they may very likely tolerate the antibiotic upon a new exposure. All patients defined as allergic should be carefully evaluated and their levels of antibiotic allergy risk determined. In cases of suspected penicillin allergy (e.g. those with cutaneous manifestations), skin tests are not necessary before prescribing a beta-lactam antibiotic (amoxicillin) and direct oral administration can be performed in low-risk phenotypes carefully selected according to simple protocols that do not always require a specialist evaluation. The article, based on the recommendations of the WHO Aware Manual, provides current evidence and practical guidance, and fosters a correct interpretation and management of an overestimated problem that does not promote an optimal and judicious antibiotic use.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":" 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140210095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lettere 信件
Q4 Medicine Pub Date : 2024-03-25 DOI: 10.53126/meb43149
{"title":"Lettere","authors":"","doi":"10.53126/meb43149","DOIUrl":"https://doi.org/10.53126/meb43149","url":null,"abstract":"","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":" 42","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140210230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Il mito dell’istinto materno: madri (e padri) non si nasce, si diventa 母性本能的神话:母亲(和父亲)不是天生的,而是后天造就的
Q4 Medicine Pub Date : 2024-03-25 DOI: 10.53126/meb43171
B. Vatta, Annina Lubbock
The still culturally widespread belief that girls and women possess an innate ‘maternal instinct’ is often a source of stress and unhappiness when new mothers struggle in caring - and even feeling love - for their newborn, as they experience the burden of social expectations that they should immediately be competent and loving. There is no evidence - either from neuroscience or ethnography and anthropology - that girls and women are ‘naturally predisposed’, differently from men, to care for and love their child. When mothers and fathers (biological or not) spend the same time in caring for and bonding with their child they develop equal competence in care. It is important to support new parents and provide an environment in which they can develop as co-parents and gain confidence in their parenting skills.
文化上仍然普遍认为,女孩和妇女拥有与生俱来的 "母性本能",这往往是新妈妈在照顾新生儿--甚至是感受到爱--方面遇到困难时的压力和不快的根源,因为她们承受着社会期望的重负,即她们应立即胜任并充满爱心。无论是从神经科学还是人种学和人类学角度,都没有证据表明女孩和妇女在照顾和爱护自己的孩子方面具有不同于男性的 "自然倾向"。当母亲和父亲(无论是否亲生)花同样的时间照顾孩子并与孩子建立亲子关系时,他们在照顾孩子方面就会发展出同等的能力。为新手父母提供支持和环境非常重要,在这样的环境中,他们可以发展成为共同父母,并对自己的育儿技能充满信心。
{"title":"Il mito dell’istinto materno: madri (e padri) non si nasce, si diventa","authors":"B. Vatta, Annina Lubbock","doi":"10.53126/meb43171","DOIUrl":"https://doi.org/10.53126/meb43171","url":null,"abstract":"The still culturally widespread belief that girls and women possess an innate ‘maternal instinct’ is often a source of stress and unhappiness when new mothers struggle in caring - and even feeling love - for their newborn, as they experience the burden of social expectations that they should immediately be competent and loving. There is no evidence - either from neuroscience or ethnography and anthropology - that girls and women are ‘naturally predisposed’, differently from men, to care for and love their child. When mothers and fathers (biological or not) spend the same time in caring for and bonding with their child they develop equal competence in care. It is important to support new parents and provide an environment in which they can develop as co-parents and gain confidence in their parenting skills.","PeriodicalId":39695,"journal":{"name":"Medico e Bambino","volume":" 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140209926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medico e Bambino
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1